ShockWave Medical Inc. has filed to raise $70 million in an IPO as it develops a way to break up calcium deposits in the circulatory system with sonic waves.
The Santa Clara company plans to trade on the Nasdaq wit the symbol of "SWAV."
It reported a $41 million net loss on $12 million in revenue for 2018.
ShockWave has raised about $150 million in funding from investors who include Venrock, T. Rowe Price, Sectoral Asset Management, Sofinnova Capital and Fidelity.
